Angiotensin Converting Enzyme Ace Inhibitors Market Size And Share

Report Code : TIPRE00020853
Category : Life Sciences

No. of Pages : 150

Buy Now

Principales conclusions et analyse des parts de marché des inhibiteurs de l'enzyme de conversion de l'angiotensine (ECA) d'ici 2025-2031

Buy Now

Angiotensin Converting Enzyme (ACE) Inhibitors Market Report Analysis

Angiotensin Converting Enzyme (ACE) Inhibitors Market

CAGR (2023 - 2031)
XX%
Market Size 2023
US$ XX million
Market Size 2031
US$ XX Million

Report Coverage

Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope

Key future trends
Detailed PEST/Porter’s Five Forces and SWOT analysis

Industry landscape and competition analysis & recent developments
Detailed company profiles

Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

Novartis AG
Pfizer, Inc
Merck & Co., Inc.
Bristol Myers Squibb
Astra and Zeneca
UCB (Schwarz Pharma Inc.)
Solvay Pharmaceuticals B.V.
Abbott
Endo International (Par Pharmaceutical, Inc.)

Regional Overview

Amérique du Nord
Europe
Asie-Pacifique
Amérique du Sud et centrale
Moyen-Orient et Afrique

Market Segmentation

By Produit

Bénazepril
Captopril
Enalapril
Fosinopril
Lisinopril
Autres

By Indication

Maladies cardiovasculaires
Hypertension
Maladies rénales chroniques
Diabète
Sclérodermie
Migraines

By Canal de distribution

pharmacies en ligne
pharmacies de détail et hospitalières

By Géographie

Amérique du Nord
Europe
Asie-Pacifique
Amérique du Sud et Centrale